89bio (NASDAQ:ETNB) Downgraded by Zacks Investment Research to Sell

89bio stock has undergone multiple analysts rating changes in the recent past.  89bio Downgraded by Zacks Investment Research on 10-12-21. In a note to investors, the firm issued a new rating of Sell. The analysts previously had rating of Hold.

Shares of 89bio traded down -$0.12 on Tuesday, reaching $18.89. 0 shares of the stock traded hands, compared to its average volume of 90024. Shares of 89bio were trading at $18.89 on Tuesday. The firm’s 50 day moving average is $19.02 and its 200 day moving average is $21.18.89bio has a 12 month low of $18.39 and a 12 month high of $28.28. While on yearly highs and lows, 89bio’s today has traded high as $19.44 and has touched $18.39 on the downward trend. See More Analyst Rating at: RATING

89bio Earnings and What to expect: 

89bio last released its earnings results on August 11th, 2021. The reported ($1.03) EPS for the quarter, missing analysts’ consensus estimates of ($0.83) by $0.20. 89bio has generated ($3.08) earnings per share over the last year (($3.26) diluted earnings per share). Earnings for 89bio are expected to decrease in the coming year, from ($3.85) to ($4.49) per share. 89bio has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, November 9th, 2021 based off prior year’s report dates.

Earnings for 89bio are expected to decrease in the coming year, from ($3.85) to ($4.49) per share. The P/E ratio of 89bio is -5.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of 89bio is -5.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. 89bio has a P/B Ratio of 1.85. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

89bio (NASDAQ:ETNB) Moving Average Technical Analysis

5 day Moving Average is $18.55 And 5 day price change is $0.61 (3.34%)  with average volume for 5 day average is 88,100. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $19.56 and 20 day price change is -$1.17 (-5.83%) and average 20 day moving volume is 90,710. 50 day moving average is $19.02  and 50 day price change is $2.14 ( 12.78%)  and with average volume for 50 days is : 86,100. 200 day moving average is $21.18  and 200 day price change is -$8.30 (-30.53%)  and with average volume for 200 days is : 118,492.

Other owners latest trading in 89bio :

  • On 8/23/2021 shares held by Morgan Stanley were 230,879 which equates to market value of $4.32M and appx 0.00% owners of 89bio
  • On 8/17/2021 shares held by Orchard Capital Managment LLC were 150,193 which equates to market value of $2.81M and appx 0.80% owners of 89bio
  • On 8/17/2021 shares held by Citadel Advisors LLC were 488,765 which equates to market value of $9.14M and appx 0.00% owners of 89bio
  • In total Institutional ownership equates to Institutional Ownership Percentage: 83.95% for 89bio

See More Analyst Rating at: RATING